Jenny Murase, MD
Dermatology · Mountain View, CANPI 1346371382
Payments from drug & device makers
Across 1,052 payments — averaging $998.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$250K
- Regeneron Healthcare Solutions, Inc.$248K
- Sanofi$229K
- Galderma Laboratories, L.p.$158K
- Lilly USA, LLC$82K
- LEO Pharma Inc.$29K
- plus $54K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 287 | $250,164 |
| Regeneron Healthcare Solutions, Inc. | 223 | $248,291 |
| Sanofi | 132 | $228,834 |
| Galderma Laboratories, L.p. | 150 | $157,749 |
| Lilly USA, LLC | 93 | $81,982 |
| LEO Pharma Inc. | 42 | $29,227 |
| AbbVie | 29 | $22,131 |
| E.r. Squibb & Sons, L.L.C. | 13 | $7,371 |
| UCB SA | 22 | $6,999 |
| Pfizer | 15 | $6,312 |
| Eli Lilly | 8 | $4,181 |
| Sanofi US Services Inc. | 1 | $2,870 |
| Arcutis Biotherapeutics, Inc. | 6 | $2,755 |
| Allerderm Laboratories | 1 | $1,000 |
| Novartis | 9 | $196 |
| Regeneron | 4 | $140 |
| Johnson & Johnson | 4 | $107 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Incyte Corporation | 4 | $87 |
| Amgen | 2 | $60 |
| Genentech USA, Inc. | 2 | $44 |
| Organon | 2 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
How this compares
$1,050,670 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Mountain View
- Amit PandyaMountain View$865K
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.